Figure 2.

Relationship between USP9X expression status and cumulative survival in ESCC (nā€‰=ā€‰102). The 5-year survival rate of patients with high USP9X expression was 31.2%, compared to 55.4% for patients with low USP9X expression (Pā€‰=ā€‰0.001).

Peng et al. Diagnostic Pathology 2013 8:177   doi:10.1186/1746-1596-8-177
Download authors' original image